Corrosion resistance isn't just about product longevity—it's a biocompatibility requirement. When metal needles contact skin (even briefly), they encounter moisture, salts, oils, and varying pH levels that can accelerate oxidation.
The Chromium Oxide Layer: Stainless steel's corrosion resistance comes from a passive chromium oxide film that forms naturally on the surface. This layer is self-healing—if scratched, chromium in the alloy reacts with oxygen to reform the protective barrier. However, this mechanism requires sufficient chromium content (minimum 10.5%) and low carbon content to prevent chromium carbide formation that would deplete available chromium [2].
Carbon's Role in Corrosion: In stainless steel metallurgy, carbon is a double-edged sword. While it increases hardness, carbon atoms bond with chromium to form chromium carbides during heat treatment or welding. These carbides remove chromium from solid solution, preventing oxide layer formation in those regions—a phenomenon called 'sensitization.' This is why 316L (low carbon, ≤0.03%) outperforms 304 (standard carbon, ≤0.08%) in corrosion-critical applications [2].
Carbon Steel's Fatal Flaw: With minimal chromium content (<1%) and carbon as the primary alloying element, carbon steel lacks the chemistry to form any protective oxide layer. In moist environments, iron oxidizes rapidly (rust), and in biological environments, iron ions can catalyze inflammatory responses. The 1924 Zierold study—still cited in modern biomaterials literature—demonstrated iron and steel dissolution in bone tissue with associated erosion [2].
Research Consensus: 'The more corrosion resistant, the more biocompatible'—this principle from PMC's comprehensive biomaterials review establishes corrosion resistance as a primary determinant of tissue compatibility for metallic implants and instruments
[2].